|
Mar 14
|
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
|
|
Mar 13
|
Guggenheim starts GH Research at Buy, sees long-term upside potential
|
|
Feb 27
|
GH Research Reports Full Year 2024 Financial Results and Provides Business Updates
|
|
Feb 24
|
GH Research PLC (GHRS): Among the Best Performing Small Cap Stocks So Far In 2025
|